Composition and method of treating temporary and permanent hearing loss

A method of claim 14 wherein the composition is administered from a kit, wherein said kit is comprised of capsules or tablets forming a daily dose wherein said daily dose comprises a combination of all of the active ingredients shown in any column of Table 2a herein, wherein the total weight of the capsule in mg is an approximate weight that includes optional components and inactive ingredients used to make the capsule;

• TABLE 2a
• Component
• Capsule Size
• Capsule
• active ingredient
• Capsule Size O
• OO
• Size OOO
• Total weight of
• 500-570
• 700-800
• 900-1150
• capsule in mg
• Vitamin E
• 34.5-39.3
• 48.3-55.2
• 62.1-79.3
• mg active/capsule
• Vitamin C
• 64.3-73.4
• 90.1-103
• 115.8-148
• mg active/capsule
• Vitamin A
• 2.3-2.7
• 3.3-3.7
• 4.2-5.3
• mg active/capsule
• as Beta-carotene
• Magnesium
• 40.7-46.4
• 57-65.1
• 73.2-93.6
• .(period)

A composition for treating hearing loss experienced by a mammal wherein said composition comprises:

• a) at least one scavenger of singlet oxygen, selected from any of:
• i) vitamin A, wherein said vitamin A scavenger of singlet oxygen has the vitamin A equivalence of at least 830 IU,
• ii) beta-carotene, wherein said beta-carotene scavenger of singlet oxygen has an activity from about 830 to 5,900 IU, (3 to 21 mg) or
• iii) resveratrol, wherein this scavenger of singlet oxygen has a singlet oxygen scavenging activity equivalent to at least 10,000 IU of vitamin A,
• or any combination thereof where the total activity of said scavenger of singlet oxygen has at least the equivalence of 830 IU of vitamin A;
• b) a donor antioxidant which is vitamin E and is present in an amount of at least 75 IU;
• c) a third antioxidant which is vitamin C and is present in an amount of at least 4,000 IU and;
• d) a vasodilator which is magnesium and it is present in an amount of at least 50 mg;